Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation

BACKGROUND: Oral dabigatran was recently approved as an alternative to warfarin for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Unlike warfarin, dabigatran has a fixed dosage and few drug interactions, and does not require anticoagulation monitoring o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Choi, Jiyoon C, DiBonaventura, Marco d, Kopenhafer, Lewis, Nelson, Winnie W
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2014
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3923612/
https://ncbi.nlm.nih.gov/pubmed/24532967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S56187
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi